Nongenomic actions of aldosterone: Physiological or pathophysiological role?

被引:21
|
作者
Mihailidou, AS [1 ]
机构
[1] Royal N Shore Hosp, Dept Cardiol, Sydney, NSW 2065, Australia
[2] Univ Sydney, Sydney, NSW 2065, Australia
关键词
aldosterone; mineralocorticoid receptor; protein kinase C (PKC); sodium pump; sodium-potassium-chloride; cotransporter;
D O I
10.1016/j.steroids.2005.09.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The actions of aldosterone are usually divided into persistent genomic mediated by the classical mineralocorticoid receptor versus acute nongenomic actions. Rapid, nongenomic effects of aldosterone have been shown in a variety of tissues, although the physiological relevance of these nongenomic actions remains to be established. There is now growing evidence that both the nongenomic and genomic actions of aldosterone, are mediated via the same classical mineralocorticoid receptor, and there is cross talk between the nongenomic and classical actions of steroid hormones. Activation of tissue-specific, second messenger pathways may contribute to integration of nongenomic and classical actions of aldosterone. Further studies are required to deter-mine the physiological or pathophysiological role of these nongenomic actions of aldosterone and whether they might amplify pathophysiological effects of aldosterone. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:277 / 280
页数:4
相关论文
共 50 条
  • [1] The nongenomic actions of aldosterone
    Funder, JW
    ENDOCRINE REVIEWS, 2005, 26 (03) : 313 - 321
  • [2] Specific nongenomic actions of aldosterone
    Falkenstein, E
    Christ, M
    Feuring, M
    Wehling, M
    KIDNEY INTERNATIONAL, 2000, 57 (04) : 1390 - 1394
  • [3] Nongenomic actions of aldosterone and progesterone revisited
    Wendler, Alexandra
    Albrecht, Christian
    Wehling, Martin
    STEROIDS, 2012, 77 (10) : 1002 - 1006
  • [4] Nongenomic actions of aldosterone on the renal tubule
    Good, David W.
    HYPERTENSION, 2007, 49 (04) : 728 - 739
  • [5] Evolving research in nongenomic actions of aldosterone
    Williams, Jonathan S.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2013, 20 (03) : 198 - 203
  • [6] Rapid nongenomic aldosterone effects - A pathophysiological factor in primary hypertension?
    Schmidt, BMW
    Rastatter, A
    Oehmer, S
    Schwarz, T
    Schneider, MP
    Delles, C
    Schmieder, RE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 514A - 514A
  • [7] Nongenomic cardiovascular actions of aldosterone: A receptor for all seasons?
    Mihailidou, AS
    ENDOCRINOLOGY, 2005, 146 (03) : 971 - 972
  • [8] Nongenomic renal effects of aldosterone - Dependency on NO and genomic actions
    Chun, TY
    Pratt, JH
    HYPERTENSION, 2006, 47 (04) : 636 - 637
  • [9] Nongenomic steroid actions: Completing the puzzle - Aldosterone as an example
    Schmidt, BMW
    Christ, M
    Falkenstein, E
    Wehling, M
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 (06) : 441 - 445
  • [10] Physiological and pathophysiological actions of insulin in the liver
    Kubota, Naoto
    Kubota, Tetsuya
    Kadowaki, Takashi
    ENDOCRINE JOURNAL, 2025, 72 (02) : 149 - 159